Skip to content
NEW: CREATE AN AI-ASSISTED TENDER IN 2 MINUTES — TRY IT FREE
Back to search
BioMS – Fertigung

Develops CE-certified point-of-care tests for molecular diagnostics, e.g. the Venus GTest for gynecology.

BioMS Logo

BioMS GmbH Molecular Science

BremenNew on Amplifa

2018Founded
2–10Employees
BremenLocation

About BioMS

BioMS GmbH Molecular Science is a medical technology company founded in 2018 and based at Fahrenheitstraße 1 in Bremen. The company develops a point-of-care platform technology based on molecular diagnostics with applications in gynecology, infectious diseases, oncology and veterinary medicine. The first application is the CE-certified Venus GTest™, which detects the three most common vaginal infections – bacterial vaginosis, trichomoniasis and candidiasis – simultaneously in around one minute from a single swab. According to LinkedIn, the company employs 2–10 people and exhibited at the Arab Health trade fair in Dubai in 2019 and 2020. The Medical Director is Dr. Saman F. Alhowaizy.

Site
Bremen
Processes
POC molecular diagnostics (point of care), Venus G Test™ – detection of bacterial vaginosis, trichomoniasis and candidiasis in ~1 minute, Point-of-care tests for women's health (Venus GTest: detection of bacterial vaginosis,, Molecular diagnostics platform technology with applications in gynecology, infectious diseases,
Materials
Molecular Point-of-Care Diagnostics (IMS Technology)
Certificates
CE certification (Venus GTest), CE Certification (Venus GTest™)
Founded
2018
Employees
2–10
Industries
Medical Technology, Gynecology / Women's Health, Infectious Disease Diagnostics, Oncology, Veterinary Diagnostics, Medical Technology (Manufacturing of Medical Devices)
  1. 01

    Research & development of the diagnostics platform

  2. 02

    Manufacturing of the test kits

  3. 03

    Quality assurance/CE certification

  4. 04

    Distribution of the point-of-care tests

Technology & Processes

POC

Molecular Point-of-Care Diagnostics (IMS Technology)

Platform technology for the rapid detection of infections from a single swab in approx. one minute.

Locations

Bremen

DE

Headquarters

Products

Venus GTest™
Venus GTest™Point-of-Care Test · Gynecology

Inside the production

BioMS Diagnostics
BioMS Diagnostics

Industries

Medical TechnologyGynecology / Women's HealthInfectious Disease DiagnosticsOncologyVeterinary DiagnosticsMedical Technology (Manufacturing of Medical Devices)

Processes & technical limits

ProcessesToleranceMax. partWeightLot sizeMaterials
POC molecular diagnostics (point of care)Testing–––––
Venus G Test™ – detection of bacterial vaginosis, trichomoniasis and candidiasis in ~1 minuteTesting–––––

Additional services

Point-of-care tests for women's health (Venus GTest: detection of bacterial vaginosis,Molecular diagnostics platform technology with applications in gynecology, infectious diseases,

Quality

The Venus GTest™ is CE-certified; the test detects the three most common vaginal infections simultaneously from a single swab.

EvidenceBremen
CE Certification (Venus GTest™)

History

  1. 2018

    Company founded according to LinkedIn

  2. 2019

    Exhibitor at Arab Health, Dubai World Trade Centre (booth Z2.K54)

  3. 2020

    Participation in Arab Health again (booth Z2.K54)

Personalised demo

Ready to see Amplifa Marketplace in action?

From a structured request to the right manufacturing partner: AI-assisted matching, verified suppliers and transparent metrics — in one place for industrial companies across the DACH region.

Request a demo